Bentley RW, Pearson J, Gearry RB, Barclay ML, et al. Association of higher DEFB4 genomic copy number with Crohn's disease. Am J Gastroenterol 2010; 105, 354-9 [Abstract]
Hollis-Moffatt JE, Gearry RB, Barclay ML, Merriman TR, Roberts RL. Consolidation of evidence for association of the KIAA1109-TENR-IL2-IL21 rs6822844 variant with Crohn's disease. Am J Gastroenterol 2010; 105, 1204-5 [Abstract]
Simms LS, Doecke JD, Roberts RL, Fowler EV, Zhao ZZ, McGuckin MA, Huang N, Hayward NK, Webb PM, Whiteman DC, Cavanaugh JA, McCallum R, Florin THJ, Barclay ML, Gearry RB, Merriman TR, Montgomery GW, Radford-Smith GL. KCNN4 Gene variant is associated with Ileal Crohn's Disease in the Australian and New Zealand population. Am J Gastroenterol 2010; 105, 2209-17 [Abstract]
McKean A, Vella-Brincat J. Regional variation in antipsychotic and antidepressant dispensing in New Zealand. Aust Psychol 2010; 185(5), 467 [Abstract]
Roberts RL, Zhang M, Marinaki AM, Stamp LK. Does genetic variability in aldehyde oxidase and molybdenum cofactor sulfurase predict non-response to allopurinol? (Letter) Aliment Pharmacol Ther 2010; 32, 310-311 [Abstract]
Stamp LK, O'Donnell JL, Chapman PT, Zhang M, James J, Frampton C, Barclay ML. Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy. Arthritis Rheumatol 2010; 62(2), 359-68 [Abstract]
Jensen BP, Bonke G. Fast and sensitive LC-MS/MS assay for quantification of nortriptyline and its active metabolites E- and Z-10-hydroxynortriptyline in human plasma. Bioanalysis 2010; 2(9), 1553-60 [Abstract]
Wright DFB, Begg EJ. The 'apparent clearance' of free phenytoin in elderly vs. younger adults. Br J Clin Pharmacol 2010; 70(1), 132-8 [Abstract]
Eglinton T, Reilly M, Chang C, Barclay ML, Frizelle F and Gearry R. Ileal disease is associated with surgery for perianal disease in a population-based Crohn's disease cohort. Br J Surg 2010; 97, 1103-9 [Abstract]
Martin JH, Norris R, Barras M, Doogue M, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Clin Biochem Rev 2010; 31(1), 21 [Abstract]
Begg EJ, Gardiner SJ, Kirkpatrick CMJ. Lactation and Contamination of Breast Milk with Xenobiotics. Comprehensive Toxicology (book) 2010; 11, 445-55 [Abstract]
Roberts RL, Topless RKG, Phipps-Green AJ, Gaerry RB, Barclay ML, Merriman TR. Evidence of interaction of CARD8 rs2043211 with NALP3 rs35829419 in Crohn's disease. Genes Immun 2010; 11, 351-6 [Abstract]
Bentley RW, Cleynen I, Gearry RB, Barclay ML, Rutgeerts P. Evidence that glioma-associated oncogene homolog 1 is not a universal risk gene for inflammatory bowel disease in Caucasians. Genes Immun 2010; 11, 509-14 [Abstract]
Doogue MP, Martin JH. Whither therapeutic drug monitoring? Intern Med J 2010; 40(10), 671-2 [Abstract]
Gearry RB, Day AS, Barclay ML, Leong RWL, Sparrow MP. Azathioprine and allopurinol: a two-edged interaction. J Gastroenterol Hepatol 2010; 25(4), 653-5 [Abstract]
Gearry RB, Glubb DM, Hollis-Moffatt JE, Topless RKG, Barclay ML, et al. Extracellular matrix protein 1 is associated with ulcerative colitis but is not implicated in Crohn's disease. J Gastroenterol Hepatol 2010; 25(S3), A80 [Abstract]
Gearry RB, Richardson AK, Frampton CM, Dodgshun AJ, Barclay ML. Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol 2010; 25(2), 325-33 [Abstract]
Ngu JH, Bechly K, Chapman BA, Burt MJ, Barclay ML, Gearry RB, Stedman AM. Population-based epidemiology study of autoimmune hepatitis: a disease of older women? J Gastroenterol Hepatol 2010; 25, 1681-6 [Abstract]
Diaz-Gallo LM, Espino-Paisan L, Fransen K, Gomez-Garcia M, Barclay ML, et al. Differential association of two PTPN22 coding variants with Crohn's disease and ulcerative colitis. J Transl Med 2010; 8, P2 [Abstract]
Valentine NA, Alhawassi TM, Roberts GW, Doogue MP, et al. Detecting undiagnosed diabetes using glycated haemoglobin: an automated screening test in hospitalised patients. Med J Aust 2011: 194, 160-4 [Abstract]
Triggs CM, Munday K, Hu R, Fraser AG, Gearry RB, Barclay ML. Dietary factors in chronic inflammation: Food tolerances and intolerances of a New Zealand Caucasian Crohn's disease population. Mutat Res 2010; 690, 123-38 [Abstract]
Franke A, McGovern DPB, Barrett JC, Wang K, Radford-Smith GL, Barclay ML, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010; 42(12), 1118-25 [Abstract]
Schultz M, Gearry R, Walmsley R, Day AS, Frasci A, Wyeth J, Barclay ML. New Zealand Society of Gastroenterology statement on the use of biological therapy in Inflammatory Bowel Disease. NZ Med J 2010; 123(1314), 134-44 [Abstract]
Roberts RL, Gearry RB, Barclay ML. Allopurinol-thiopurine combination therapy in inflammatory bowel disease: are there genetic clues to this puzzle? Pharmacogenomics 2010; 11(11), 1505-8 [Abstract]
Stamp LK, Chapman PT, O'Donnell JL, Zhang M, James J, Frampton C, Barclay ML, Kennedy MA, Roberts RL. Polymorphisms within the folate pathway predict folate concentrations but are not associated with disease activity in rheumatoid arthritis patients on methotrexate. Pharmacogenet Genomics 2010; 20(6), 367-76 [Abstract]
Stewart C, Day AS, Pearson J, Barclay ML, Gearry RB, Roberts R. SLC11A1 polymorphisms in inflammatory bowel disease and Mycobacterium avium subspecies paratuberculosis status. World J Gastroenterol 2010; 16(45), 5725-31 [Abstract]
Vella-Brincat JWA, Begg EJ, Robertshawe BJ, Lynn AM, Borrie TL. Are gentamicin and/or vancomycin associated with ototoxicity in the neonate? A retrospective audit. Neonatology 2010; 100(2), 186-93 [Abstract]
